• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受根治性切除的甲胎蛋白阴性肝细胞癌患者早期复发的预测列线图。

A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection.

作者信息

Li Wencui, Han Lizhu, Xiao Bohan, Li Xubin, Ye Zhaoxiang

机构信息

Department of Radiology, Liver Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Huanhu Xi Road, Tiyuan Bei, Hexi District, Tianjin 300060, China.

Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin 300060, China.

出版信息

Diagnostics (Basel). 2022 Apr 25;12(5):1073. doi: 10.3390/diagnostics12051073.

DOI:10.3390/diagnostics12051073
PMID:35626229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9140180/
Abstract

Background: Alpha-fetoprotein-negative (<20 ng/mL) hepatocellular carcinoma (AFP-NHCC) cannot be easily diagnosed in clinical practice, which may affect early treatment and prognosis. Furthermore, there are no reliable tools for the prediction of AFP-NHCC early recurrence that have been developed currently. The objective of this study was to identify the independent risk factors for AFP-NHCC and construct an individual prediction nomogram of early recurrence of these patients who underwent curative resection. Methods: A retrospective study of 199 patients with AFP-NHCC who had undergone curative resection and another 231 patients with AFP-positive HCC were included in case-controlled analyses. All AFP-NHCC patients were randomly divided into training and validation datasets at a ratio of 7:3. The univariate and multivariate Cox proportional hazards regression analyses were applied to identify the risk factors, based on which the predictive nomogram of early recurrence was constructed in the training dataset. The area under the curve (AUC), calibration curve, and decision curve was used to evaluate the predictive performance and discriminative ability of the nomogram, and the results were validated in the validation dataset. Results: Compared to AFP-positive patients, the AFP-negative group with lower values of laboratory parameters, lower tumor aggressiveness, and less malignant magnetic resonance (MR) imaging features. AST (HR = 2.200, p = 0.009), tumor capsule (HR = 0.392, p = 0.017), rim enhancement (HR = 2.825, p = 0.002) and TTPVI (HR = 5.511, p < 0.001) were independent predictors for early recurrence of AFP-NHCC patients. The nomogram integrated these independent predictors and achieved better predictive performance with AUCs of 0.89 and 0.85 in the training and validation datasets, respectively. The calibration curve and decision curve analysis both demonstrated better predictive efficacy and discriminative ability of the nomogram. Conclusions: The nomogram based on the multivariable Cox proportional hazards regression analysis presented accurate individual prediction for early recurrence of AFP-NHCC patients after surgery. This nomogram could assist physicians in personalized treatment decision-making for patients with AFP-NHCC.

摘要

背景

甲胎蛋白阴性(<20 ng/mL)的肝细胞癌(AFP-NHCC)在临床实践中不易诊断,这可能会影响早期治疗和预后。此外,目前尚未开发出用于预测AFP-NHCC早期复发的可靠工具。本研究的目的是确定AFP-NHCC的独立危险因素,并构建接受根治性切除的这些患者早期复发的个体预测列线图。方法:对199例接受根治性切除的AFP-NHCC患者和另外231例AFP阳性肝癌患者进行回顾性研究,并纳入病例对照分析。所有AFP-NHCC患者按7:3的比例随机分为训练集和验证集。应用单因素和多因素Cox比例风险回归分析来识别危险因素,并在此基础上在训练集中构建早期复发的预测列线图。采用曲线下面积(AUC)、校准曲线和决策曲线来评估列线图的预测性能和鉴别能力,并在验证集中对结果进行验证。结果:与AFP阳性患者相比,AFP阴性组的实验室参数值较低、肿瘤侵袭性较低且恶性磁共振(MR)成像特征较少。AST(HR = 2.200,p = 0.009)、肿瘤包膜(HR = 0.392,p = 0.017)、边缘强化(HR = 2.825,p = 0.002)和TTPVI(HR = 5.511,p < 0.001)是AFP-NHCC患者早期复发的独立预测因素。该列线图整合了这些独立预测因素,在训练集和验证集中的AUC分别为0.89和0.85,具有更好的预测性能。校准曲线和决策曲线分析均显示列线图具有更好的预测效能和鉴别能力。结论:基于多变量Cox比例风险回归分析的列线图对AFP-NHCC患者术后早期复发提供了准确的个体预测。该列线图可协助医生为AFP-NHCC患者进行个性化治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/ba2b0afb396e/diagnostics-12-01073-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/0c744b1a6493/diagnostics-12-01073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/a3d7c0df4c51/diagnostics-12-01073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/fca02ff85b38/diagnostics-12-01073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/e4bc87535372/diagnostics-12-01073-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/ba2b0afb396e/diagnostics-12-01073-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/0c744b1a6493/diagnostics-12-01073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/a3d7c0df4c51/diagnostics-12-01073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/fca02ff85b38/diagnostics-12-01073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/e4bc87535372/diagnostics-12-01073-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3372/9140180/ba2b0afb396e/diagnostics-12-01073-g005.jpg

相似文献

1
A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection.接受根治性切除的甲胎蛋白阴性肝细胞癌患者早期复发的预测列线图。
Diagnostics (Basel). 2022 Apr 25;12(5):1073. doi: 10.3390/diagnostics12051073.
2
Development and validation of a prognostic nomogram to predict the recurrence of AFP-negative and DCP-positive hepatocellular carcinoma after curative resection.用于预测根治性切除术后甲胎蛋白阴性且异常凝血酶原阳性肝细胞癌复发的预后列线图的开发与验证
Front Oncol. 2024 Aug 8;14:1414083. doi: 10.3389/fonc.2024.1414083. eCollection 2024.
3
A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.基于 LASSO Cox 回归的 AFP 阴性肝癌患者非手术治疗后预后列线图。
BMC Cancer. 2021 Mar 8;21(1):246. doi: 10.1186/s12885-021-07916-3.
4
Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation.使用创新的肝功能-营养-炎症-免疫(LFNII)评分构建并验证预测甲胎蛋白阴性肝细胞癌术后复发的新型列线图:一项双中心研究。
J Hepatocell Carcinoma. 2024 Mar 6;11:489-508. doi: 10.2147/JHC.S451357. eCollection 2024.
5
Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.基于术前至术后甲胎蛋白比值的列线图预测肝细胞癌患者的肿瘤复发情况
Front Oncol. 2023 Apr 14;13:1134933. doi: 10.3389/fonc.2023.1134933. eCollection 2023.
6
New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.新的列线图可预测术前血清甲胎蛋白阴性且接受根治性切除的肝细胞癌患者的复发情况。
J Surg Oncol. 2018 Jun;117(7):1540-1547. doi: 10.1002/jso.25046. Epub 2018 Mar 24.
7
Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.基于血小板-白蛋白-胆红素的列线图预测甲胎蛋白阴性肝细胞癌患者术后肿瘤复发情况
J Hepatocell Carcinoma. 2023 Jan 13;10:43-55. doi: 10.2147/JHC.S396433. eCollection 2023.
8
Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.基于白蛋白-胆红素(ALBI)和单核细胞与淋巴细胞比值(MLR)的列线图模型预测甲胎蛋白阴性肝细胞癌的肿瘤复发情况
J Hepatocell Carcinoma. 2021 Nov 12;8:1355-1365. doi: 10.2147/JHC.S339707. eCollection 2021.
9
[Analysis of the diagnostic efficiency of combining multiple laboratory hematological indicators in alpha-fetoprotein-negative hepatocellular carcinoma].[多种实验室血液学指标联合诊断甲胎蛋白阴性肝细胞癌的效能分析]
Zhonghua Yi Xue Za Zhi. 2022 May 10;102(17):1303-1310. doi: 10.3760/cma.j.cn112137-20220115-00103.
10
Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma.甲胎蛋白阴性肝细胞癌诊断列线图模型的建立与验证
Front Oncol. 2023 Feb 20;13:1131892. doi: 10.3389/fonc.2023.1131892. eCollection 2023.

引用本文的文献

1
A novel nomogram based on machine learning predicting overall survival for hepatocellular carcinoma patients with dynamic α‑fetoprotein level changes after local resection.一种基于机器学习的新型列线图,用于预测局部切除术后甲胎蛋白水平动态变化的肝细胞癌患者的总生存期。
Oncol Lett. 2025 Apr 24;29(6):310. doi: 10.3892/ol.2025.15056. eCollection 2025 Jun.
2
Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis.基于计算机断层扫描的放射组学预测肝硬化背景下肝癌患者肝切除术后早期复发。
World J Gastroenterol. 2024 Apr 21;30(15):2128-2142. doi: 10.3748/wjg.v30.i15.2128.
3

本文引用的文献

1
Two-Trait Predictor of Venous Invasion on Contrast-Enhanced CT as a Preoperative Predictor of Outcomes for Early-Stage Hepatocellular Carcinoma After Hepatectomy.增强CT上静脉侵犯的双特征预测指标作为肝切除术后早期肝细胞癌预后的术前预测指标
Front Oncol. 2021 Sep 1;11:688087. doi: 10.3389/fonc.2021.688087. eCollection 2021.
2
Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.钆塞酸增强 MRI 特征对手术后增殖型肝细胞癌具有预后价值。
Radiology. 2021 Sep;300(3):572-582. doi: 10.1148/radiol.2021204352. Epub 2021 Jul 6.
3
Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma.
Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
甲胎蛋白阴性肝细胞癌患者生存预测及预后因素分析:一项基于人群的研究。
BMC Gastroenterol. 2024 Mar 4;24(1):93. doi: 10.1186/s12876-024-03185-z.
4
Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation.AFP和DCP双阴性肝细胞癌患者局部消融后预后列线图的开发与验证
J Hepatocell Carcinoma. 2024 Feb 3;11:271-284. doi: 10.2147/JHC.S442366. eCollection 2024.
5
Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma.CE-CT 放射组学预测肝癌中高 Ki-67 表达的增值。
BMC Med Imaging. 2023 Sep 22;23(1):138. doi: 10.1186/s12880-023-01069-4.
6
Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.用于预测接受局部区域治疗且甲胎蛋白动态变化的肝细胞癌患者复发的列线图的开发与验证。
Front Oncol. 2023 Aug 28;13:1206345. doi: 10.3389/fonc.2023.1206345. eCollection 2023.
7
Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.hsa-miR-21-5p、hsa-miR-192-5p、hsa-miR-155-5p、hsa-miR-199a-5p 联合检测及其比值对 HCV 感染患者合并肝硬化的肝细胞癌的诊断意义。
Int J Mol Sci. 2023 Feb 5;24(4):3157. doi: 10.3390/ijms24043157.
8
Pre-operative MRI features predict early post-operative recurrence of hepatocellular carcinoma with different degrees of pathological differentiation.术前 MRI 特征可预测不同病理分化程度的肝细胞癌术后早期复发。
Radiol Med. 2023 Mar;128(3):261-273. doi: 10.1007/s11547-023-01601-0. Epub 2023 Feb 10.
9
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development.确定异常凝血酶原(PIVKA-II)用于监测肝细胞癌发生风险患者的最佳临界值
Biology (Basel). 2023 Jan 7;12(1):94. doi: 10.3390/biology12010094.
不可切除肝细胞癌中免疫检查点抑制剂反应的生化预测因子。
Cancer Treat Res Commun. 2021;27:100328. doi: 10.1016/j.ctarc.2021.100328. Epub 2021 Feb 2.
4
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
5
Development and validation of a novel nomogram predicting 10-year actual survival after curative hepatectomy for hepatocellular carcinoma.开发和验证一种新的列线图,用于预测肝癌根治性肝切除术后 10 年实际生存率。
Surgeon. 2021 Dec;19(6):329-337. doi: 10.1016/j.surge.2020.11.013. Epub 2021 Jan 8.
6
[Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].[不同中国肝癌分期肝细胞癌患者根治性肝切除术后的临床疗效及预后因素分析]
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):134-143. doi: 10.3760/cma.j.cn112139-20200803-00605.
7
Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.术前预测对单个肝细胞癌患者的早期复发可与术后评估一样准确。
Korean J Radiol. 2020 Apr;21(4):402-412. doi: 10.3348/kjr.2019.0538.
8
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.甲胎蛋白在肝细胞癌中的生物学特性及意义。
Liver Int. 2019 Dec;39(12):2214-2229. doi: 10.1111/liv.14223. Epub 2019 Sep 11.
9
Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.R0 肝切除治疗 T1 期肝细胞癌患者手术切缘宽度对复发模式的影响:一项国际多机构分析。
J Gastrointest Surg. 2020 Jul;24(7):1552-1560. doi: 10.1007/s11605-019-04275-0. Epub 2019 Jun 26.
10
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.